Literature DB >> 17035397

Comparison of age distribution patterns for different histopathologic types of breast carcinoma.

William F Anderson1, Ruth M Pfeiffer, Graça M Dores, Mark E Sherman.   

Abstract

BACKGROUND: Historically, female breast carcinoma has been viewed as an etiologically homogeneous disease associated with rapidly increasing incidence rates until age 50 years, followed by a slower rate of increase among older women. More recent studies, however, have shown distinct age incidence patterns for female breast cancer when stratified by estrogen receptor (ER) expression and/or histopathologic subtypes, suggesting etiologic heterogeneity.
MATERIALS AND METHODS: To determine if different age incidence patterns reflect etiologic heterogeneity (more than one breast cancer type within the general breast carcinoma), we applied "smoothed" age histograms at diagnosis (density plots) and a two-component statistical mixture model to all breast carcinoma cases (n = 270,124) in the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. These overall patterns were then reevaluated according to histopathologic type, race, and ER expression.
RESULTS: A bimodal age distribution at diagnosis provided a better fit to the data than a single density for all breast carcinoma populations, except for medullary carcinoma. Medullary carcinomas showed a single age distribution at diagnosis irrespective of race and/or ER expression.
CONCLUSIONS: Distinct age-specific incidence patterns reflected bimodal breast cancer populations for breast carcinoma overall as well as for histopathologic subtypes, race, and ER expression. The one exception was medullary carcinoma. Of note, medullary carcinomas are rare tumors, which are associated with germ-line mutations in the BRCA1 gene. These descriptive and model-based results support emerging molecular data, suggesting two main types of breast carcinoma in the overall breast cancer population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035397     DOI: 10.1158/1055-9965.EPI-06-0191

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  56 in total

1.  Aromatase inhibitor associated arthralgia: the importance of oncology provider-patient communication about side effects and potential management through physical activity.

Authors:  Kirsten A Nyrop; Leigh F Callahan; Christine Rini; Mary Altpeter; Betsy Hackney; Amy DePue; Anne Wilson; Arielle Schechter; Hyman B Muss
Journal:  Support Care Cancer       Date:  2016-01-12       Impact factor: 3.603

2.  Qualitative age interactions in breast cancer studies: mind the gap.

Authors:  William F Anderson; Ismail Jatoi; Mark E Sherman
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

Review 3.  [Lobular neoplasms and invasive lobular breast cancer].

Authors:  H-P Sinn; B Helmchen; J Heil; S Aulmann
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

4.  Differential Patterns of Risk Factors for Early-Onset Breast Cancer by ER Status in African American Women.

Authors:  Kimberly A Bertrand; Traci N Bethea; Lucile L Adams-Campbell; Lynn Rosenberg; Julie R Palmer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-10-18       Impact factor: 4.254

5.  Suspicious breast calcifications undergoing stereotactic biopsy in women ages 70 and over: Breast cancer incidence by BI-RADS descriptors.

Authors:  Lars J Grimm; David Y Johnson; Karen S Johnson; Jay A Baker; Mary Scott Soo; E Shelley Hwang; Sujata V Ghate
Journal:  Eur Radiol       Date:  2016-10-17       Impact factor: 5.315

6.  Glucocorticoid receptor expression in breast cancer associates with older patient age.

Authors:  Larissa Belova; Bertha Delgado; Masha Kocherginsky; Amal Melhem; Olufunmilayo I Olopade; Suzanne D Conzen
Journal:  Breast Cancer Res Treat       Date:  2008-07-31       Impact factor: 4.872

7.  Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.

Authors:  Mohammed S Fayaz; Mustafa S El-Sherify; Amany El-Basmy; Sadeq A Zlouf; Nashwa Nazmy; Thomas George; Susan Samir; Gerges Attia; Heba Eissa
Journal:  Rep Pract Oncol Radiother       Date:  2013-09-26

8.  Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway.

Authors:  Grethe Albrektsen; Ivar Heuch; Steinar Ø Thoresen
Journal:  BMC Cancer       Date:  2010-05-21       Impact factor: 4.430

9.  Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study.

Authors:  Bassam Ghabach; William F Anderson; Rochelle E Curtis; Mark M Huycke; Jackie A Lavigne; Graça M Dores
Journal:  Breast Cancer Res       Date:  2010-07-23       Impact factor: 6.466

10.  Parallel routes of human carcinoma development: implications of the age-specific incidence data.

Authors:  James P Brody
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.